This November, hundreds of minds will meet in San Diego for the annual International Neuroethics Society (INS) conference. The program is packed with experts from around the world who will be discussing important issues regarding social, legal, and ethical implications of advances in neuroscience.
It is estimated that between 26.4 million and 36 million people abuse opioids worldwide; the US government estimates that 2.1 million people in the United States have substance use disorders related to prescription opioid pain relievers in 2012 and another 467,000 are addicted to heroin. Consequences include a spike in the number of unintentional overdose deaths from prescription pain relievers (including the recent death of the musician Prince), and growing evidence to suggest a relationship between increased non-medical use of opioid analgesics and heroin abuse in the US.
What can we do to help? This spring, Charles O’Brien and colleagues reported results of the latest in a series of studies testing the drug naltrexone as a preventive against opioid relapse in people greatly at risk for relapse: formerly addicted convicts. “This U.S. multisite, open-label, randomized effectiveness trial showed that among adult offenders who had a history of opioid dependence, the rate of relapse was lower among participants assigned to extended-release naltrexone than among those assigned to usual treatment,” they write.
The European Dana Alliance for the Brain (EDAB) presents two Outreach Champion Awards with the Federation of European Neurosciences Societies (FENS) every two years at the biennial FENS Forum of Neuroscience. The 2016 winners were announced during an awards ceremony on July 4th at this year’s FENS Forum in Copenhagen, Denmark.
The Dana/EDAB Neuroscience Outreach Champion, also known as The David and Hillie Mahoney Award for an Individual’s Contribution to Outreach, is presented to a person who has significantly contributed to the promotion of brain awareness, through continued public outreach efforts for a period of three or more years. This year’s winner is Paul Bolam, emeritus professor and senior scientist at the Medical Research Council’s Brain Networks Dynamics Unit at the University of Oxford. His outreach includes 75 talks over the last seven years, usually covering topics such as the aging brain and Parkinson’s disease.
Global life expectancy has gone up 39 years since 1900 and is predicted to rise at least another six years by 2050, according to a United Nations forecast. With people living longer than ever, geriatric research is of vital importance.
London’s annual Successful Ageing program, titled “Live Longer, Live Well – Seize the Day!” focused on the history of geriatric research and new, promising advances. The event was jointly organized by the European Dana Alliance for the Brain and the University of the Third Age.
Professor Richard Faragher, University of Brighton, briefed the audience on topics from genes that may lengthen life to senescent cell elimination, which could slow the effects of aging. We have come a long way in understanding the aging process and are moving towards higher quality, longer lives, he said.
Check out the full video for information on the latest advances:
– Ali Chunovic
Need a book to take with you on your summer vacation? We have six brainy suggestions, all written by members of the Dana Alliance for Brain Initiatives (DABI) or prominent neuroscientists, that are perfect for a sunny day:
The Teenage Brain: A Neuroscientist’s Survival Guide to Raising Adolescents and Young Adults, by DABI member Frances E. Jensen, M.D., HarperCollins
“Jensen provides her sound scientific expertise and presents experimental brain data, as well as her firsthand practice of parenting through vignettes about her sons’ sometimes questionable behavior—hair dye, a car crash, her response to a son having too much to drink as a college student. Jensen also presents humorous, cliché, and disheartening teen stories and testimonials from parents who have sought her advice.” – Marisa M. Silveri, Ph.D., Cerebrum